BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10023324)

  • 1. Matrix metalloproteinase digestion of aggrecan in human cartilage tumours.
    Toriyama M; Rosenberg AE; Mankin HJ; Fondren T; Treadwell BV; Towle CA
    Eur J Cancer; 1998 Nov; 34(12):1969-73. PubMed ID: 10023324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro.
    Hughes CE; Caterson B; Fosang AJ; Roughley PJ; Mort JS
    Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):799-804. PubMed ID: 7531436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan.
    Büttner FH; Hughes CE; Margerie D; Lichte A; Tschesche H; Caterson B; Bartnik E
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):159-65. PubMed ID: 9639575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an antibody against the matrix metalloproteinase-generated aggrecan neoepitope FVDIPEN-COOH to assess the effects of stromelysin in a rabbit model of cartilage degradation.
    Bayne EK; MacNaul KL; Donatelli SA; Christen A; Griffin PR; Hoerrner LA; Calaycay JR; Ayala JM; Chapman K; Hagmann W
    Arthritis Rheum; 1995 Oct; 38(10):1400-9. PubMed ID: 7575690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interglobular domain of cartilage aggrecan is cleaved by hemorrhagic metalloproteinase HT-d (atrolysin C) at the matrix metalloproteinase and aggrecanase sites.
    Tortorella MD; Pratta MA; Fox JW; Arner EC
    J Biol Chem; 1998 Mar; 273(10):5846-50. PubMed ID: 9488721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggrecan degradation in human intervertebral disc and articular cartilage.
    Sztrolovics R; Alini M; Roughley PJ; Mort JS
    Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):235-41. PubMed ID: 9337874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunolocalization of the cleavage of the aggrecan core protein at the Asn341-Phe342 bond, as an indicator of the location of the metalloproteinases active in the lysis of the rat growth plate.
    Lee ER; Lamplugh L; Leblond CP; Mordier S; Magny MC; Mort JS
    Anat Rec; 1998 Sep; 252(1):117-32. PubMed ID: 9737748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation.
    Little CB; Hughes CE; Curtis CL; Janusz MJ; Bohne R; Wang-Weigand S; Taiwo YO; Mitchell PG; Otterness IG; Flannery CR; Caterson B
    Matrix Biol; 2002 Apr; 21(3):271-88. PubMed ID: 12009333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B.
    Fosang AJ; Neame PJ; Last K; Hardingham TE; Murphy G; Hamilton JA
    J Biol Chem; 1992 Sep; 267(27):19470-4. PubMed ID: 1326552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated catabolism of aggrecan. Evidence that cleavage at the "aggrecanase" site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain.
    Lark MW; Gordy JT; Weidner JR; Ayala J; Kimura JH; Williams HR; Mumford RA; Flannery CR; Carlson SS; Iwata M
    J Biol Chem; 1995 Feb; 270(6):2550-6. PubMed ID: 7852317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases.
    Stanton H; Ung L; Fosang AJ
    Biochem J; 2002 May; 364(Pt 1):181-90. PubMed ID: 11988091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.
    Fosang AJ; Last K; Maciewicz RA
    J Clin Invest; 1996 Nov; 98(10):2292-9. PubMed ID: 8941646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP).
    Stracke JO; Fosang AJ; Last K; Mercuri FA; Pendás AM; Llano E; Perris R; Di Cesare PE; Murphy G; Knäuper V
    FEBS Lett; 2000 Jul; 478(1-2):52-6. PubMed ID: 10922468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain.
    Oshita H; Sandy JD; Suzuki K; Akaike A; Bai Y; Sasaki T; Shimizu K
    Biochem J; 2004 Aug; 382(Pt 1):253-9. PubMed ID: 15175011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymes active in the areas undergoing cartilage resorption during the development of the secondary ossification center in the tibiae of rats ages 0-21 days: I. Two groups of proteinases cleave the core protein of aggrecan.
    Lee ER; Lamplugh L; Davoli MA; Beauchemin A; Chan K; Mort JS; Leblond CP
    Dev Dyn; 2001 Sep; 222(1):52-70. PubMed ID: 11507769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.
    Lark MW; Williams H; Hoernner LA; Weidner J; Ayala JM; Harper CF; Christen A; Olszewski J; Konteatis Z; Webber R
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):245-52. PubMed ID: 7717983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids.
    Fosang AJ; Last K; Gardiner P; Jackson DC; Brown L
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):337-43. PubMed ID: 7544117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage.
    Flannery CR; Lark MW; Sandy JD
    J Biol Chem; 1992 Jan; 267(2):1008-14. PubMed ID: 1730630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.